Topical corticosteroids with FxCO2 in patients with VLSC was associated with significant pruritus improvement and patient satisfaction.

Q VYJUVEK global revenue and $846.7 million since launchEnrollment complete in KB803 (corneal abrasions in DEB patients) ...

Krystal Biotech leverages its HSV-1 gene delivery platform, with VYJUVEK generating strong cash flow. Read why I rate KRYS ...

EVERSANA, a purpose-built, partner-led commercial organization, positions Candel for potential U.S. commercial launch following planned BLA ...

Q VYJUVEK global revenue and $846.7 million since launch Enrollment complete in KB803 (corneal abrasions in DEB patients) registrational study On track for KB803 and KB801 (NK) registrational ...

In a double-blind, placebo-controlled phase 2 randomized clinical trial, vemircopan did not meet the predefined efficacy ...

Johnson & Johnson today announced Phase 2b data from two studies evaluating JNJ-4804, an investigational co-antibody therapy targeting both interleukin-23 (IL-23) and tumor necrosis factor-alpha (TNF- ...

A team at Kindai University in Osaka, Japan, fed ordinary L-arginine to fruit flies and mice engineered to develop ...

Forbes contributors publish independent expert analyses and insights. Daisy Auger-Domínguez writes about work, culture, and careers. Changing jobs isn't just about paychecks, though paychecks matter.

Bristol Myers Squibb today announced that the European Commission has granted approval to Sotyktu (deucravacitinib), alone or in combination with methotrexate, for the treatment of active psoriatic ...

Have you ever found yourself wondering, “What else?” “What’s next?” or “Is this the life I want to be living?” Whether it’s a habit change, a career shift, or a deeper evolution of who you are, the ...

Change is inevitable, but the amount of change and uncertainty that groups and organizations across industries and sectors are experiencing right now is significant. According to the PwC 2024 Global ...